Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Nerve block may ease pain after breast implants, study finds

NCT ID NCT02682186

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a nerve block called the pectoral block (Pecs block) can reduce pain after cosmetic breast augmentation. 74 women scheduled for surgery were randomly assigned to receive either the block or a sham procedure. The main goal was to see if the block lowered pain scores in the first six hours after surgery. The results could help improve recovery for people undergoing this common procedure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ropivacaine (a local anesthetic)
What this could lead to
If it works, this could offer a simple, effective way to manage pain after breast augmentation surgery.
What could go wrong
This is a small, completed Phase 3 trial. The results may not apply to all patients or settings, and the technique carries risks like any nerve block.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

74 people

The number who actually took part.

Started

Feb 2016

Finished

Jul 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Affiliated to a national insurance scheme * Having signed the informed consent for this study * Score of American Society of Anesthesiology ( ASA) 1-3 * Be hospitalized in the ambulatory care unit (UCA) or plastic surgery service for a scheduled esthetic prosthetic breast expansion surgery. Exclusion Criteria: * Protected minor or major patients or in the incapacity to give his consent according to the article L1121-8 of the Code of the Health Public. * Pregnant or breast-feeding women according to French law. * Vulnerable people. * Patients participating in another research * Allergy with local anesthetics. * Severe coagulopathy. * Chronic painful Patients (long-term treatment by analgesics) * Contraindication to use analgesics of the protocol. * Change of breast prostheses

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ambulatory plastic surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Nîmes

    Nîmes, Nîmes, 30029, France

  • UH Montpellier

    Montpellier, 34295, France

  • UH Montpellier - Hôpital Gui de Chauliac

    Montpellier, 34295, France